Gene targeting in stem cells from individuals with osteogenesis imperfecta - PubMed (original) (raw)

. 2004 Feb 20;303(5661):1198-201.

doi: 10.1126/science.1088757.

Affiliations

• PMID: 14976317
• DOI: 10.1126/science.1088757

Gene targeting in stem cells from individuals with osteogenesis imperfecta

Joel R Chamberlain et al. Science. 2004.

Abstract

Adult stem cells offer the potential to treat many diseases through a combination of ex vivo genetic manipulation and autologous transplantation. Mesenchymal stem cells (MSCs, also referred to as marrow stromal cells) are adult stem cells that can be isolated as proliferating, adherent cells from bones. MSCs can differentiate into multiple cell types present in several tissues, including bone, fat, cartilage, and muscle, making them ideal candidates for a variety of cell-based therapies. Here, we have used adeno-associated virus vectors to disrupt dominant-negative mutant COL1A1 collagen genes in MSCs from individuals with the brittle bone disorder osteogenesis imperfecta, demonstrating successful gene targeting in adult human stem cells.

PubMed Disclaimer

Similar articles

• Targeting gene therapy for osteogenesis imperfecta.
  Prockop DJ. Prockop DJ. N Engl J Med. 2004 May 27;350(22):2302-4. doi: 10.1056/NEJMcibr040806. N Engl J Med. 2004. PMID: 15163783 No abstract available.
• Progenitors systemically transplanted into neonatal mice localize to areas of active bone formation in vivo: implications of cell therapy for skeletal diseases.
  Wang X, Li F, Niyibizi C. Wang X, et al. Stem Cells. 2006 Aug;24(8):1869-78. doi: 10.1634/stemcells.2005-0430. Epub 2006 May 4. Stem Cells. 2006. PMID: 16675597
• Emerging therapeutic approaches for osteogenesis imperfecta.
  Millington-Ward S, McMahon HP, Farrar GJ. Millington-Ward S, et al. Trends Mol Med. 2005 Jun;11(6):299-305. doi: 10.1016/j.molmed.2005.04.006. Trends Mol Med. 2005. PMID: 15949772 Review.
• Mutations in type I collagen genes resulting in osteogenesis imperfecta in humans.
  Gajko-Galicka A. Gajko-Galicka A. Acta Biochim Pol. 2002;49(2):433-41. Acta Biochim Pol. 2002. PMID: 12362985 Review.

Cited by

• Trisomy correction in Down syndrome induced pluripotent stem cells.
  Li LB, Chang KH, Wang PR, Hirata RK, Papayannopoulou T, Russell DW. Li LB, et al. Cell Stem Cell. 2012 Nov 2;11(5):615-9. doi: 10.1016/j.stem.2012.08.004. Epub 2012 Oct 18. Cell Stem Cell. 2012. PMID: 23084023 Free PMC article.
• Gene delivery to bone.
  Evans CH. Evans CH. Adv Drug Deliv Rev. 2012 Sep;64(12):1331-40. doi: 10.1016/j.addr.2012.03.013. Epub 2012 Mar 26. Adv Drug Deliv Rev. 2012. PMID: 22480730 Free PMC article. Review.
• Human LIGIV is synthetically lethal with the loss of Rad54B-dependent recombination and is required for certain chromosome fusion events induced by telomere dysfunction.
  Oh S, Wang Y, Zimbric J, Hendrickson EA. Oh S, et al. Nucleic Acids Res. 2013 Feb 1;41(3):1734-49. doi: 10.1093/nar/gks1326. Epub 2012 Dec 28. Nucleic Acids Res. 2013. PMID: 23275564 Free PMC article.
• Osteogenesis imperfecta: new treatment options.
  Chevrel G, Cimaz R. Chevrel G, et al. Curr Rheumatol Rep. 2006 Dec;8(6):474-9. doi: 10.1007/s11926-006-0044-0. Curr Rheumatol Rep. 2006. PMID: 17092446 Review.
• Why the apparent haste to clone humans?
  Cobbe N. Cobbe N. J Med Ethics. 2006 May;32(5):298-302. doi: 10.1136/jme.2005.011981. J Med Ethics. 2006. PMID: 16648282 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • BioCyc
  • Gene Ontology

• Miscellaneous

  • NCI CPTAC Assay Portal